Storgaard H, Cold F, Gluud LL, Vilsbll T, Knop FK
In scientific updates, a new study (GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy) suggests that taking a GLP-1 may be associated with an increased risk of developing NAION, a type of eye stroke that can cause sudden, permanent blindness
Before starting treatment, we require patients to complete a consultation to assess your health history and ensure this medicine is safe for you
When the opportunity arose in 2020 to join Lilly and work in the early-phase group that brings new molecules forward to be tested as potential treatments for obesity and diabetes, I decided to take it
Krizelle Hilahan Reviews Loved by Our Clients Get In Touch With Us Schedule Your Free Consultation Take Your First Step Today Let our team of Medical Professionals help you achieve your body goals